Viiv Health Care Nasdaq

Listing Websites about Viiv Health Care Nasdaq

Filter Type:

ViiV Healthcare announces U.S. FDA approval of …

(7 days ago) WEBDURHAM, N.C., April 08, 2024--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the …

https://finance.yahoo.com/news/viiv-healthcare-announces-u-fda-122300021.html

Category:  Health Show Health

GSK/Pfizer-Backed ViiV Healthcare's HIV Treatment At Par With …

(Just Now) WEBViiV Healthcare, majority-owned by GSK Plc (NYSE: GSK), Pfizer Inc (NYSE: PFE), and Shionogi Limited, announced 12-month findings from the SOLAR Phase 3b study of the …

https://finance.yahoo.com/news/gsk-pfizer-backed-viiv-healthcares-154336744.html

Category:  Health Show Health

GlaxoSmithKline's ViiV Healthcare Receives FDA Approval For

(4 days ago) WEBPublished. Feb 1, 2022 10:39PM EST. (RTTNews) - ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline plc (GSK, GSK.L), with Pfizer and …

https://www.nasdaq.com/articles/glaxosmithklines-viiv-healthcare-receives-fda-approval-for-hiv-treatment

Category:  Health Show Health

ViiV Healthcare Announces Interim Data at CROI Indicating …

(4 days ago) WEBLONDON, March 06, 2024--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced …

https://finance.yahoo.com/news/viiv-healthcare-announces-interim-data-170500968.html

Category:  Health Show Health

ViiV Healthcare to present data for its next generation of ultra long

(7 days ago) WEBHere is a list of ViiV Healthcare-sponsored or supported studies to be presented at CROI 2024: Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time. …

https://www.morningstar.com/news/business-wire/20240223777191/viiv-healthcare-to-present-data-for-its-next-generation-of-ultra-long-acting-treatments-for-hiv

Category:  Health Show Health

ViiV Healthcare's Cabenuva Shows Superiority In HIV Viral Load

(6 days ago) WEB(RTTNews) - ViiV Healthcare announced results from an interim analysis of the LATITUDE phase III trial, indicating their long-acting injectable antiretroviral treatment (ART) for …

https://markets.businessinsider.com/news/stocks/viiv-healthcare-s-cabenuva-shows-superiority-in-hiv-viral-load-suppression-interim-trial-analysis-1033086273

Category:  Health Show Health

ViiV Healthcare Announces FDA's Priority Review Designation

(8 days ago) WEBSep 28, 2021 7:00AM EDT. (RTTNews) - ViiV Healthcare announced the FDA has accepted and granted priority review for a New Drug Application for investigational …

https://www.nasdaq.com/articles/viiv-healthcare-announces-fdas-priority-review-designation-for-cabotegravir-2021-09-28

Category:  Health Show Health

ViiV Healthcare and Halozyme enter global collaboration and …

(2 days ago) WEBLondon and San Diego, 22 June 2021 – ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi …

https://viivhealthcare.com/en-us/media-center/news/press-releases/2021/june/viiv-healthcare-and-halozyme-enter-global-collaboration/

Category:  Health Show Health

ViiV Healthcare Announces Interim Data at CROI Indicating …

(3 days ago) WEBAbout ViiV Healthcare. ViiV Healthcare is a global specialist HIV company established in November 2009 by GSK (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering …

https://www.morningstar.com/news/business-wire/20240305691015/viiv-healthcare-announces-interim-data-at-croi-indicating-superior-efficacy-of-long-acting-injectable-hiv-treatment-cabenuva-cabotegravir-rilpivirine-compared-to-daily-oral-therapy-in-individuals-living-with-hiv-who-have-adherence-challenges

Category:  Health Show Health

ViiV Healthcare collaborates with Halozyme for development of …

(3 days ago) WEBViiV Healthcare and Halozyme Therapeutics (NASDAQ: HALO) announce a global collaboration and license agreement that gives exclusive access to Halozyme's …

https://seekingalpha.com/news/3708520-viiv-healthcare-collaborates-with-halozyme-for-development-of-hiv-medicines

Category:  Health Show Health

ViiV Healthcare announces new packaging option now available in …

(8 days ago) WEBDURHAM, N.C., February 06, 2024--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced …

https://finance.yahoo.com/news/viiv-healthcare-announces-packaging-option-160000818.html

Category:  Health Show Health

ViiV Healthcare Announces First Global Regulatory Approval of

(7 days ago) WEBViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that Health Canada has …

https://www.nasdaq.com/press-release/viiv-healthcare-announces-first-global-regulatory-approval-of-cabenuva-the-first

Category:  Health Show Health

GSK: ViiV Healthcare Gets FDA Approval For HIV Treatment …

(5 days ago) WEB(RTTNews) - GlaxoSmithKline plc (GSK, GSK.L) said Friday that its majority-owned specialist HIV company ViiV Healthcare has received approval from the US Food and …

https://markets.businessinsider.com/news/stocks/gsk-viiv-healthcare-gets-fda-approval-for-hiv-treatment-cabenuva-quick-facts-1029993099

Category:  Food Show Health

ViiV Healthcare announces interim data at CROI indicating …

(8 days ago) WEBViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced data from a planned interim …

https://www.marketscreener.com/quote/stock/PFIZER-INC-23365019/news/ViiV-Healthcare-announces-interim-data-at-CROI-indicating-superior-efficacy-of-long-acting-injectabl-46111440/

Category:  Health Show Health

ViiV Healthcare presents phase I clinical trial findings of a

(1 days ago) WEBViiV Healthcare is a global specialist HIV company established in November 2009 by GSK (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and …

https://www.morningstar.com/news/business-wire/20240302118910/viiv-healthcare-presents-phase-i-clinical-trial-findings-of-a-cabotegravir-long-acting-injectable-investigational-formulation-allowing-at-least-four-months-between-doses

Category:  Health Show Health

ViiV Healthcare Announces Health Canada Approval for APRETUDE

(8 days ago) WEBApproved for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV infection in at-risk adults and adolescents aged 12 years and older,

https://www.barchart.com/story/news/26160103/viiv-healthcare-announces-health-canada-approval-for-apretude-cabotegravir-tablets-and-extended-release-injectable-suspension-for-pre-exposure-prophylaxis-prep-to-reduce-the-risk-of-sexually-acquired-hiv

Category:  Health Show Health

A leader in HIV Medicines and Research ViiV Healthcare US

(3 days ago) WEBWe are the only pharmaceutical company solely focused on combating, preventing and, ultimately, curing HIV and AIDS. But, of course, none of what we do can be achieved …

https://viivhealthcare.com/en-us/

Category:  Course Show Health

ViiV Healthcare and the Medicines Patent Pool Sign New - Nasdaq

(1 days ago) WEBViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, and the Medicines Patent Pool today announced the signing …

https://www.nasdaq.com/press-release/viiv-healthcare-and-the-medicines-patent-pool-sign-new-voluntary-licensing-agreement

Category:  Medicine Show Health

About ViiV and the HIV Treatments ViiV Healthcare US

(4 days ago) WEBUntil the 38 million people living with HIV is down to zero, we will continue searching for new ways to limit the impact of HIV. 1. Born out of a partnership between GSK and Pfizer in …

https://viivhealthcare.com/en-us/about-viiv/

Category:  Health Show Health

ViiV Healthcare announces new packaging option now available

(Just Now) WEBViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced Dovato is now available in a blister pack in …

https://www.nasdaq.com/press-release/viiv-healthcare-announces-new-packaging-option-now-available-in-the-u.s.-for-dovato

Category:  Health Show Health

ViiV Healthcare and UNC-Chapel Hill announce five-year renewal …

(2 days ago) WEBViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, and the University of North Carolina at Chapel …

https://www.nasdaq.com/press-release/viiv-healthcare-and-unc-chapel-hill-announce-five-year-renewal-of-innovative-hiv-cure

Category:  Health Show Health

Filter Type: